Subtype
Anterior Pituitary Gland Neoplasm
CI-CAN-00000452Explore in graph →
Non-malignant21 active trials
- NCIt
- C45921
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000452Explore in graph →
Clinical trials
100 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | active not recruiting | Phase 2 | 798 | National Cancer Institute (NCI)NIH | 2 | Jun 17, 2026 | clinicaltrials |
| NCT03583528 | DOTATOC PET/CT for Imaging NET Patients | active not recruiting | — | 800 | British Columbia Cancer AgencyOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT03465618 |
| A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors |
| active not recruiting |
| Phase 1 |
| 17 |
| Memorial Sloan Kettering Cancer CenterOTHER |
| 1 |
| May 1, 2026 |
| clinicaltrials |
| NCT07446036 | Prediction Model for Postoperative Headache After Transsphenoidal Pituitary Surgery | active not recruiting | — | 500 | Beijing Tiantan HospitalOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT06936813 | The PROMISE Survey | active not recruiting | — | 530 | University Hospital, Basel, SwitzerlandOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT06664190 | Pre-operative Surgical Difficulty Stratification Using Predicted Tumor Perfusion and Consistency | active not recruiting | — | 200 | Huashan HospitalOTHER | 1 | Oct 29, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Jun 17, 2026source: clinicaltrials